These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2899514)

  • 1. Intracerebral SCH 23390 and catalepsy in the rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1988 Apr; 149(1-2):175-8. PubMed ID: 2899514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats.
    Rowlett JK; Pedigo NW; Bardo MT
    Pharmacol Biochem Behav; 1991 Dec; 40(4):829-34. PubMed ID: 1840081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration.
    Lappalainen J; Hietala J; Syvälahti E
    Psychopharmacology (Berl); 1989; 98(4):472-5. PubMed ID: 2570432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.
    Ozer H; Ekinci AC; Starr MS
    Brain Res; 1997 Nov; 777(1-2):51-9. PubMed ID: 9449412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood.
    Hietala J; Seppäla T; Lappalainen J; Syvälahti E
    Psychopharmacology (Berl); 1992; 106(4):455-8. PubMed ID: 1349751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral hypothalamus-zona incerta region as an output station for the catalepsy induced by the blockade of striatal D1 and D2 dopamine receptors.
    Ossowska K; Wardas J; Golembiowska K; Wolfarth S
    Brain Res; 1990 Jan; 506(2):311-5. PubMed ID: 2154287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat.
    Caine SB; Heinrichs SC; Coffin VL; Koob GF
    Brain Res; 1995 Sep; 692(1-2):47-56. PubMed ID: 8548319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant action of SCH 23390 in the striatum of the rat.
    al-Tajir G; Starr MS
    Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the role of 5-HT(2) receptor antagonism during subchronic antipsychotic drug administration in rats.
    Kruzich PJ; See RE
    Brain Res; 2000 Sep; 875(1-2):35-43. PubMed ID: 10967296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic maturation and SCH 23390-induced catalepsy in the male rat pup.
    Fitzgerald LW; Hannigan JH
    Brain Res Dev Brain Res; 1989 May; 47(1):147-50. PubMed ID: 2525433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 19. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
    Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.